- Home
- RNR vs ASND Comparison
RNR vs ASND Comparison
Compare RNR & ASND Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RNR
- ASND
- Stock Information
- Founded
- RNR 1993
- ASND 2006
- Country
- RNR Bermuda
- ASND Denmark
- Employees
- RNR N/A
- ASND N/A
- Industry
- RNR Property-Casualty Insurers
- ASND Biotechnology: Pharmaceutical Preparations
- Sector
- RNR Finance
- ASND Health Care
- Exchange
- RNR Nasdaq
- ASND Nasdaq
- Market Cap
- RNR 11.8B
- ASND 10.6B
- IPO Year
- RNR 1995
- ASND 2015
- Fundamental
- Price
- RNR $243.72
- ASND $170.86
- Analyst Decision
- RNR Buy
- ASND Strong Buy
- Analyst Count
- RNR 12
- ASND 16
- Target Price
- RNR $283.45
- ASND $218.19
- AVG Volume (30 Days)
- RNR 400.3K
- ASND 435.4K
- Earning Date
- RNR 07-23-2025
- ASND 05-01-2025
- Dividend Yield
- RNR 0.66%
- ASND N/A
- EPS Growth
- RNR N/A
- ASND N/A
- EPS
- RNR 31.81
- ASND N/A
- Revenue
- RNR $12,613,932,000.00
- ASND $398,509,511.00
- Revenue This Year
- RNR N/A
- ASND $75.05
- Revenue Next Year
- RNR $0.99
- ASND $78.14
- P/E Ratio
- RNR $7.65
- ASND N/A
- Revenue Growth
- RNR 31.51
- ASND 12.06
- 52 Week Low
- RNR $208.98
- ASND $111.09
- 52 Week High
- RNR $300.00
- ASND $183.00
- Technical
- Relative Strength Index (RSI)
- RNR 46.24
- ASND 52.37
- Support Level
- RNR $240.16
- ASND $166.84
- Resistance Level
- RNR $248.28
- ASND $180.78
- Average True Range (ATR)
- RNR 4.98
- ASND 5.57
- MACD
- RNR -0.57
- ASND -0.53
- Stochastic Oscillator
- RNR 37.44
- ASND 38.59
About RNR RenaissanceRe Holdings Ltd.
RenaissanceRe Holdings Ltd provides reinsurance and insurance solutions and related services. The company's core products include property, casualty and specialty reinsurance. Revenue is derived from three sources: net premiums earned from the insurance and insurance products sold; net investment income from the investment of capital funds and cash; and other income from the company's joint ventures, advisory services, and other items. The reportable segments of the company are the Property segment which includes catastrophe and other property reinsurance, and the Casualty and Specialty segment which is comprised of casualty and specialty reinsurance. It derives a majority of its revenue from the Casualty and specialty segment.
About ASND Ascendis Pharma A/S
Ascendis Pharma AS is a biopharmaceutical company that applies its TransCon technology platform to make a meaningful difference for patients. The firm's product pipeline includes Endocrinology and Oncology which includes TransCon PTH, TransCon CNP, and others. It operates in North America, Europe, and Rest of the world and derives the majority of its revenue from North America.